HMGN1 and precursor B-cell acute lymphoblastic leukemia: In B-ALL, elevated levels of HMGN1 reduce the levels of H3K27me3, a histone modification associated with gene silencing, and increase the levels of H3K27ac, a modification associated with increased gene expression, thereby leading to transcriptional amplification and promoting B cell proliferation [52,53].